About Grand Hôpital de Charleroi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Daiichi Sankyo, Inc.
1
Janssen-Cilag International NV
1
Pfizer
1
Seagen Inc.
1
Clinical Trials at Grand Hôpital de Charleroi
During the past decade, Grand Hôpital de Charleroi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
2017-08-29
2032-08-31
Recruiting
105
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
2018-12-27
2023-03-01
Active, not recruiting
557
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
2019-02-27
2024-09-30
Active, not recruiting
214
Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
Available
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Grand Hôpital de Charleroi"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Genmab" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Grand Hôpital de Charleroi
According to Clinical.Site data, the most researched conditions in "Grand Hôpital de Charleroi" are
"Atopic Dermatitis" (1 trials), "Breast Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Grand Hôpital de Charleroi" in a lesser frequency.
Clinical Trials Intervention Types at Grand Hôpital de Charleroi
Most popular intervention types in "Grand Hôpital de Charleroi" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Eribulin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Grand Hôpital de Charleroi
The vast majority of trials in "Grand Hôpital de Charleroi" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Grand Hôpital de Charleroi
Currently, there are NaN active trials in "Grand Hôpital de Charleroi".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Grand Hôpital de Charleroi,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Grand Hôpital de Charleroi, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".